Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.

Key facts

Study ID

NCT01217918

Run by

Pfizer

People needed

30

Starts

2010-10-01

Expected to finish

2011-02-01

Last updated by the study team

2011-02-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy Volunteers
• Japanese

You may not qualify if…

• Subjects with clinically significant skin lesions
• Subjects with known tuberculosis infection

Where it is running

• Pfizer Investigational Site — Culver City, California, United States
• Pfizer Investigational Site — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.